邮件订阅 RSS

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

82例糖原累积症Ⅰa型肝脏受累特点

唐晓艳,  陈萌,  马明圣,  李明,  邱正庆

downloadPDF
文章导航 > 协和医学杂志  > 2014 >  5(4): 405-407
唐晓艳, 陈萌, 马明圣, 李明, 邱正庆. 82例糖原累积症Ⅰa型肝脏受累特点[J]. 协和医学杂志, 2014, 5(4): 405-407. doi: 10.3969/j.issn.1674-9081.2014.04.010
引用本文: 唐晓艳, 陈萌, 马明圣, 李明, 邱正庆. 82例糖原累积症Ⅰa型肝脏受累特点[J]. 协和医学杂志, 2014, 5(4): 405-407. doi: 10.3969/j.issn.1674-9081.2014.04.010
shu
Xiao-yan TANG, Meng CHEN, Ming-sheng MA, Ming Li, Zheng-qing QIU. Characteristic Liver Manifestations of Glycogen Storage Disease Type Ⅰa: A Retrospective Study of 82 Cases[J]. Medical Journal of Peking Union Medical College Hospital, 2014, 5(4): 405-407. doi: 10.3969/j.issn.1674-9081.2014.04.010
Citation: Xiao-yan TANG, Meng CHEN, Ming-sheng MA, Ming Li, Zheng-qing QIU. Characteristic Liver Manifestations of Glycogen Storage Disease Type Ⅰa: A Retrospective Study of 82 Cases[J]. Medical Journal of Peking Union Medical College Hospital, 2014, 5(4): 405-407. doi: 10.3969/j.issn.1674-9081.2014.04.010
shu

82例糖原累积症Ⅰa型肝脏受累特点

doi: 10.3969/j.issn.1674-9081.2014.04.010

  • 中国医学科学院 北京协和医学院 北京协和医院儿科, 北京 100730

详细信息
    通讯作者:

    邱正庆 电话:010-69156276, E-mail:zhengqingqiu33@aliyun.com

  • 中图分类号: R725.8

Characteristic Liver Manifestations of Glycogen Storage Disease Type Ⅰa: A Retrospective Study of 82 Cases

  • Department of Pediatrics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

More Information

    摘要
  • 摘要:   目的  探讨糖原累积症(glycogen storage disease, GSD)Ⅰa型的肝脏受累特点。  方法  回顾性分析2006年1月至2013年12月在北京协和医院住院治疗的82例基因确诊为GSD Ⅰa型患儿的临床资料及肝脏影像学结果, 并总结其肝脏受累特点。  结果  82例GSDⅠa型患儿中, 男55例, 女27例; 出现症状平均年龄为(1.2±0.9)岁, 其中42例(54.9%)以发现肝脏肿大为首要原因就诊。13.4%(11/82)患儿出现肝脏腺瘤, 腺瘤出现年龄平均(15.7±3.0)岁(12~23岁); 63.6%(7/11)为多发腺瘤, 36.4%(4/11)为单发腺瘤。单发肝脏腺瘤均位于肝脏右叶, 多发腺瘤均表现为左叶及右叶均有分布。1例患儿行肝动脉栓塞治疗, 1例合并腺瘤癌变。  结论  GSD Ⅰa型是小儿较常见的导致肝脏肿大的遗传代谢病之一, 至青春期左右易发生肝脏腺瘤, 部分癌变。定期随诊腹部超声意义重大。对年长儿不明原因的多发肝脏腺瘤要注意鉴别GSD Ⅰa型。
    Abstract:   Objective  To summarize the characteristic liver manifestations of glycogen storage disease type Ⅰa(GSD Ⅰa).  Methods  We retrospectively analyzed the clinical data and liver image results of 82 genetically diagnosed GSD Ⅰa patients hospitalized in Peking Union Medical College Hospital between January 2006 and December 2013, and summarized the characteristics of liver involvement of these patients.  Results  The 82 patients included 55 boys and 27 girls. Their symptoms developed at the mean age of (1.2±0.9) years. Forty-two patients (54.9%) visited doctors because of hepatomegaly. Eleven(13.4%) had hepatic adenomas, which appeared at the age of (15.7±3.0) years (12-23 years). Among them, 63.6% (7/11) had multiple adenomas, and the other(36.4%, 4/11) had single ones. The single adenomas were all located in the right lobe of the liver, and the multiple adenomas all involved both left and right lobes of the liver. One child received hepatic arterial embolization. One child had adenoma with canceration.  Conclusions  GSD Ⅰa is one of the most common hereditary metabolic diseases, which can cause hepatomegaly in chidren and liver adenoma in adolescents, some developing into cancer. Regular follow-up with abdominal ultrasound examination is important. In differential diagnosis of multiple liver adenomas of unknown origin in older children, attention should be paid to the possibility of GSD Ⅰa.
    • HTML全文
    • 参考文献(13)
  • [1] Chou JY, Mansfield BC. Mutations in the glucose-6-phosphatase-alpha (G6PC) gene that cause type Ⅰa glycogen storage disease[J]. Hum Mutat, 2008, 29:921-930. doi:  10.1002/humu.20772
    [2] Carvalho PM, Silva NJ, Dias PG, et al. Glcogen Storage Disease type 1a-a secondary cause for hyperlipidemia:report of five cases[J]. J Diabetes Metab Disord, 2013, 12:25. doi:  10.1186/2251-6581-12-25
    [3] Chen YT, Cornblath M, Sidbury JB. Cornstarch therapy in type Ⅰ glycogen-storage disease[J]. N Engl J Med, 1984, 310:171-175. doi:  10.1056/NEJM198401193100306
    [4] Chou JY, Jun HS, Mansfield BC. Glycogen storage disease type Ⅰ and G6Pase-β deficiency:etiology and therapy[J]. Nat Rev Endocrinol, 2010, 6:676-688. doi:  10.1038/nrendo.2010.189
    [5] Mason HH, Andersen DH. Glycogen disease of the liver (von Gierke's disease) with hepatomata; case report with metabolic studies[J]. Pediatrics, 1955, 16:785-800. http://europepmc.org/abstract/MED/13273118
    [6] Rake, JP, Visser G, Labrune P, et al. Glycogen storage disease type Ⅰ:diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease type Ⅰ (ESGSD I)[J]. Eur J Pediatr, 2002, 161:S20-S34. doi:  10.1007/s00431-002-0999-4
    [7] Wang DQ, Fiske LM, Carreras CT, et al. Natural history of hepatocellular adenoma formation in glycogen storage disease type Ⅰ[J]. J Pediatr, 2011, 159:442-446. doi:  10.1016/j.jpeds.2011.02.031
    [8] Di Rocco M, Calevo MG, Taro M, et al. Hepatocellular adenoma and metabolic balance in patients with type Ⅰa glycogen storage disease[J]. Mol Genet Metab, 2008, 93:398-402. doi:  10.1016/j.ymgme.2007.10.134
    [9] Kishnani PS, Chuang TP, Bali D, et al. Chromosomal and genetic alterations in human hepatocellular adenomas associated with type Ⅰa glycogen storage disease[J]. Hum Mol Genet, 2009, 18:4781-4190. doi:  10.1093/hmg/ddp441
    [10] Zucman-Rossi J, Jeannot E, Nhieu JT, et al. Genotype-phenotype correlation in hepatocellular adenoma:new classification and relationship with HCC[J]. Hepatology, 2006, 43:515-524. doi:  10.1002/hep.21068
    [11] Weinstein DA, Wolfsdorf JI. Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease[J]. Eur J Pediatr, 2002, 161:S35-S39. doi:  10.1007/s00431-002-1000-2
    [12] Lee YM, Jun HS, Pan CJ, et al. Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ⅰa by gene therapy[J]. Hepatology, 2012, 56:1719-1729. doi:  10.1002/hep.25717
    [13] Janice YC, Hyun SJ, Brian CM. Glycogen storage disease type Ⅰ and G6Pase-beta deficiency:etiology and therapy[J]. Nat Rev Endocrinol, 2010, 6:676-688. doi:  10.1038/nrendo.2010.189
    • 相关文章
    • 施引文献
  • 资源附件(0)
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  17
  • HTML全文浏览量:  5
  • PDF下载量:  3
  • 被引次数: 0
出版历程
  • 收稿日期:  2014-08-13
  • 刊出日期:  2014-10-30

目录

    /

    返回文章
    返回
    友情链接: 国家卫生健康委员会 北京协和医院 中国医学科学院 学术不端检测系统 国际知识资源总库 中国知网 术语在线 中国全科医学
    地址：北京市东城区帅府园1号 北京协和医院老楼7号楼
    3层302室 《协和医学杂志》编辑部
    电话：010-69154261/4262
    E - mail：medj@pumch.cn
    mjpumch@126.com
    期刊网站版权所有：《协和医学杂志》编辑部
    京ICP备 11002662

    本系统由 北京仁和汇智信息技术有限公司 开发    百度统计

    x 关闭 永久关闭

    【温馨提醒】近日，《协和医学杂志》编辑部接到作者反映，有多名不法人员冒充期刊编辑发送见刊通知，鼓动作者添加微信，从而骗取版面费的行为。特提醒您，本刊与作者联系的方式均为邮件通知或电话，稿件进度通知邮箱为：mjpumch@126.com，编辑部电话为：010-69154261，请提高警惕，谨防上当受骗！如有任何疑问，请致电编辑部核实。谢谢！